BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31039627)

  • 1. Guidelines for optimized gene knockout using CRISPR/Cas9.
    Campenhout CV; Cabochette P; Veillard AC; Laczik M; Zelisko-Schmidt A; Sabatel C; Dhainaut M; Vanhollebeke B; Gueydan C; Kruys V
    Biotechniques; 2019 Jun; 66(6):295-302. PubMed ID: 31039627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of zebrafish models by CRISPR /Cas9 genome editing.
    Hruscha A; Schmid B
    Methods Mol Biol; 2015; 1254():341-50. PubMed ID: 25431076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs.
    Rose JC; Popp NA; Richardson CD; Stephany JJ; Mathieu J; Wei CT; Corn JE; Maly DJ; Fowler DM
    Nat Commun; 2020 Jun; 11(1):2697. PubMed ID: 32483117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved method for precise genome editing in zebrafish using CRISPR-Cas9 technique.
    Gasanov EV; Jędrychowska J; Pastor M; Wiweger M; Methner A; Korzh VP
    Mol Biol Rep; 2021 Feb; 48(2):1951-1957. PubMed ID: 33481178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
    Schindele P; Wolter F; Puchta H
    Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
    Chen S; Lee B; Lee AY; Modzelewski AJ; He L
    J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
    Berkhout B; Gao Z; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized CRISPR-Cas9 System for Genome Editing in Zebrafish.
    Vejnar CE; Moreno-Mateos MA; Cifuentes D; Bazzini AA; Giraldez AJ
    Cold Spring Harb Protoc; 2016 Oct; 2016(10):. PubMed ID: 27698232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice.
    Hana S; Peterson M; McLaughlin H; Marshall E; Fabian AJ; McKissick O; Koszka K; Marsh G; Craft M; Xu S; Sorets A; Torregrosa T; Sun C; Henderson CE; Lo SC
    Gene Ther; 2021 Nov; 28(10-11):646-658. PubMed ID: 33558692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells.
    Lin C; Li H; Hao M; Xiong D; Luo Y; Huang C; Yuan Q; Zhang J; Xia N
    Sci Rep; 2016 Oct; 6():34531. PubMed ID: 27713537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
    Bai B; Myklebust JH; Wälchli S
    Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Functional Genetic Study Models in Zebrafish Using CRISPR-Cas9.
    Carmona-Aldana F; Nuñez-Martinez HN; Peralta-Alvarez CA; Tapia-Urzua G; Recillas-Targa F
    Methods Mol Biol; 2021; 2174():255-262. PubMed ID: 32813255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Design of gRNA for CRISPR/Cas9-Mediated Gene Knockout.
    Freudhofmaier M; Hoyle JW; Maghuly F
    Methods Mol Biol; 2024; 2788():287-294. PubMed ID: 38656521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Transgenic Mice Using CRISPR /Cas9 Technology.
    El Marjou F; Jouhanneau C; Krndija D
    Methods Mol Biol; 2021; 2214():125-141. PubMed ID: 32944907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.